CLOV as reported
Clover Health Investments, Corp. reported $2.48B of revenue over the trailing twelve months, +54% on the year before. 10 reported series are charted on this page, each one as filed.
$2.48B
Revenue, trailing twelve months · to Q2 2026 · +54% against the twelve months before
- Free Cash Flow
- $74M
Free Cash Flow · −254% year on year · trailing twelve months to Q2 2026
- Op Margin
- −1.9%
Op Margin · trailing twelve months to Q2 2026
- EPS
- −$0.05
EPS · −37% year on year · trailing twelve months to Q2 2026
| Series | Latest | Year on year | As of |
|---|---|---|---|
| Revenue | $2.48B | +54% | Q2 2026 |
| Net Income | −$91M | n/a | Q3 2024 · 7 quarters behind |
| EPS | −$0.05 | −37% | Q2 2026 |
| Gross Margin | 25% | n/a | Q3 2024 · 7 quarters behind |
| Op Margin | −1.9% | n/a | Q2 2026 |
| Net Margin | −7.2% | n/a | Q3 2024 · 7 quarters behind |
| ROE | −48% | n/a | Q3 2024 · 7 quarters behind |
| ROA | −23% | n/a | Q3 2024 · 7 quarters behind |
| ROIC | −349% | n/a | Q4 2022 · 14 quarters behind |
| Free Cash Flow | $74M | −254% | Q2 2026 |
Every figure straight from the statements as filed with the SEC, no scoring, no adjustment. Open a series for its full history.
Clover Health Investments, Corp. (CLOV) - Revenue & ProfitRevenue & ProfitClover Health Investments, Corp. (CLOV)
Revenue (TTM)Net Income (TTM)
Powered byryufin.com
Healthcare Plans
Ranks #2 of 11 by Smart Score